Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Cell(2021)10.1016/j.cell.2021.02.037Source: DataRank Database

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 1,157 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1,157 citations

Download PDF

Cite:

Linked data & code

gen cellosaurus nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (34 grants)OA: hybridTopics (73)Linked Datasets (22)DataCite Reuse (22)IDs (PubMed, PMC)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (44)

Wanwisa Dejnirattisai ORCID,Piyada Supasa ORCID,Chang Liu ORCID,Alexander J. Mentzer ORCID,Helen M. Ginn ORCID

Live enrichment

PubMed:33730597 PMC:PMC7901269

Medical Research Council

Grant: ACE2

Medical Research Council

Grant: MR/N00065X/1

Structural Studies on Viruses, Viral Proteins and Cell Interactions

Medical Research Council

Grant: 203141/Z/16/Z

Medical Research Council

Grant: 095541/A/11/Z

Medical Research Council

Grant: 090532/Z/09/Z

National Institutes of Health

Grant: U19 I082360

National Institutes of Health

Grant: WT204969/Z/16/Z

Wellcome Trust

Grant: 101122/Z/13/Z

Cancer Research UK

Grant: C375/A17721

China Academy of Chinese Medical Sciences

Grant: 2018-I2M-2-002

Wellcome Trust

Grant: 203224/Z/16/Z

National Institute for Health Research (NIHR)

Grant: ACF-2018-13-005

National Institute for Health Research (NIHR)

Grant: CL-2018-13-007

Wellcome Trust

Grant: 204969/Z/16/Z

Medical Research Council

Grant: MR/V001329/1

National Institute for Health Research (NIHR)

Grant: NF-SI-0515-10005

National Institute for Health Research (NIHR)

Grant: COV19OxfordVaccine01

Medical Research Council

Grant: MR/L018942/1

Wellcome Trust

Grant: 109965/Z/15/Z

Medical Research Council

Grant: MC_PC_19055

National Institute for Health Research (NIHR)

Grant: NIHR300791

National Institute for Health Research (NIHR)

Grant: NF-SI-0617-10139

Wellcome Trust

Grant: 204969

Characterising extreme innate immune response phenotypes informative for disease using a functional genomics approach

Wellcome Trust

Grant: 101122

Improved control of endemic foot-and-mouth disease by development of virus like particle vaccines

Wellcome Trust

Grant: 095541

Studies of immunopathogenesis in dengue virus infection.

Wellcome Trust

Grant: 95541

Studies of immunopathogenesis in dengue virus infection.

Wellcome Trust

Grant: 203141

Human Genetics and Disease Biology: Core Renewal for the Wellcome Trust Centre for Human Genetics

Wellcome Trust

Grant: 090532

Understanding the genetic basis of common human diseases: core funding for the Wellcome Trust Centre for Human Genetics.

Chinese Academy of Medical Sciences

Public Health England

NIHR Oxford Biomedical Research Centre

UK Research and Innovation

National Institute for Health Research (NIHR)

Coalition for Epidemic Preparedness Innovations

hybridLicense: cc-by

publisherhttps://doi.org/10.1016/j.cell.2021.02.037

publisherhttps://api.elsevier.com/content/article/PII:S0092867421002269?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421002269?httpAccept=text/plain

repositoryhttps://ora.ox.ac.uk/objects/uuid:b14d4861-8366-4b81-92aa-3a87168bb1c9

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7901269

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Vero CellsAnimalsHumansAntibodies, MonoclonalNeutralization TestsImmunization, PassiveProtein BindingMutationModels, MolecularClinical Trials as TopicHEK293 CellsChlorocebus aethiopsCOVID-19SARS-CoV-2COVID-19 VaccinesCOVID-19 Serotherapy

Keywords

VariantAntibodyVaccineNeutralizationACE2Receptor-binding domainSouth AfricaEscapeSars-cov-2B.1.351Models, MolecularInfectious disease (medical specialty)FOS: Health sciencesCoronavirus Disease 2019Agricultural and Biological SciencesChlorocebus aethiopsPathologyDiseaseClinical Trials as TopicVaccinesAntibodies, MonoclonalLife SciencesInfectious DiseasesMedicineProtein BindingReceptorMonoclonal antibodyCOVID-19 VaccinesImmunologyCoronavirus Disease 2019 ResearchArticleBetacoronavirusNeutralization TestsVirologyHealth SciencesGeneticsAnimalsHumansViral Diseases in Livestock and PoultryVero CellsBiologyCOVID-19 SerotherapySpike ProteinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)FOS: Clinical medicineImmunization, PassiveCOVID-19Neutralizing antibodyCoronavirusCoronavirus disease 2019 (COVID-19)HEK293 CellsFOS: Biological sciencesMutationAnimal Science and Zoology

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305772.v1figshare

Additional file 1 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305772figshare

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699.v1figshare

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699figshare

Additional file 1 of Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis

10.6084/m9.figshare.19845824.v1figshare

Additional file 1 of Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis

10.6084/m9.figshare.19845824figshare

Additional file 2 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305775.v1figshare

Additional file 3 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305778.v1figshare

Additional file 2 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305775figshare

Additional file 3 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305778figshare

Additional file 6 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305787.v1figshare

Additional file 5 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305784.v1figshare

Additional file 5 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305784figshare

Additional file 6 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305787figshare

Additional file 4 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305781.v1figshare

Additional file 4 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

10.6084/m9.figshare.16305781figshare

Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815708.v1figshare

Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815705figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702.v1figshare